Company intelligence / Profile preview

The Pinnacle Fund

Plano, Texas, United States

Ownership: Private
Development stage: Other

Overview

The Pinnacle Fund, L.P. was a prominent investment partnership and hedge fund founded in 1993 by Barry M. Kitt. While not a biotechnology company itself, the fund was a significant and active investor in the life sciences and healthcare sectors, particularly in companies focused on biopharmaceuticals and medical technologies. Notable investments included China Biologic Products, Dyadic International, and NexMed. The fund officially closed in 2010, with its assets transitioning into the Pinnacle Family Office Investments, L.P.

Industry: Investors

Beyond the preview

Go deeper on The Pinnacle Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Pinnacle Fund.

Explore the full profile